17.37
0.45 (2.66%)
| Penutupan Terdahulu | 16.92 |
| Buka | 16.86 |
| Jumlah Dagangan | 118,458 |
| Purata Dagangan (3B) | 162,222 |
| Modal Pasaran | 1,068,545,152 |
| Harga / Jualan (P/S) | 60.23 |
| Harga / Buku (P/B) | 10.07 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 27 Mar 2025 |
| EPS Cair (TTM) | -0.920 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 7.75% |
| Nisbah Semasa (MRQ) | 11.88 |
| Aliran Tunai Operasi (OCF TTM) | -36.34 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -17.92 M |
| Pulangan Atas Aset (ROA TTM) | -36.70% |
| Pulangan Atas Ekuiti (ROE TTM) | -67.31% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Menurun | Bercampur |
| Medical Instruments & Supplies (Global) | Menurun | Menurun | |
| Stok | Pulse Biosciences, Inc | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | 4.0 |
| Purata | 0.75 |
|
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 73.90% |
| % Dimiliki oleh Institusi | 9.00% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Panoramic Capital, Llc | 31 Dec 2024 | 48,571 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |